These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27377046)

  • 1. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.
    Thiabaud G; McCall R; He G; Arambula JF; Siddik ZH; Sessler JL
    Angew Chem Int Ed Engl; 2016 Oct; 55(41):12626-31. PubMed ID: 27377046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.
    Thiabaud G; He G; Sen S; Shelton KA; Baze WB; Segura L; Alaniz J; Munoz Macias R; Lyness G; Watts AB; Kim HM; Lee H; Cho MY; Hong KS; Finch R; Siddik ZH; Arambula JF; Sessler JL
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7021-7029. PubMed ID: 32179677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z; Wang Z; Yiu SM; Zhu G
    Dalton Trans; 2015 Dec; 44(46):19918-26. PubMed ID: 26514681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
    Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motexafin gadolinium: a novel redox active drug for cancer therapy.
    Magda D; Miller RA
    Semin Cancer Biol; 2006 Dec; 16(6):466-76. PubMed ID: 17112739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt
    Reshetnikov V; Daum S; Mokhir A
    Chemistry; 2017 Apr; 23(24):5678-5681. PubMed ID: 28319647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Anticancer Pt
    Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
    Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex.
    Venkatesh V; Wedge CJ; Romero-Canelón I; Habtemariam A; Sadler PJ
    Dalton Trans; 2016 Aug; 45(33):13034-7. PubMed ID: 27189101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
    Huo S; Shen S; Liu D; Shi T
    J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H; Xu Z; Li C; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2019 Aug; 58(16):11076-11084. PubMed ID: 31393117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
    Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
    J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
    Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
    Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.
    Medrano MÁ; Álvarez-Valdés A; Perles J; Lloret-Fillol J; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
    Chem Commun (Camb); 2013 May; 49(42):4806-8. PubMed ID: 23591566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs.
    McCormick MC; Keijzer K; Polavarapu A; Schultz FA; Baik MH
    J Am Chem Soc; 2014 Jun; 136(25):8992-9000. PubMed ID: 24853204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt
    Ma L; Wang N; Ma R; Li C; Xu Z; Tse MK; Zhu G
    Angew Chem Int Ed Engl; 2018 Jul; 57(29):9098-9102. PubMed ID: 29806087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.